These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12358232)

  • 1. Quality of life in patients with Barrett's esophagus undergoing surveillance.
    Fisher D; Jeffreys A; Bosworth H; Wang J; Lipscomb J; Provenzale D
    Am J Gastroenterol; 2002 Sep; 97(9):2193-200. PubMed ID: 12358232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does cancer risk affect health-related quality of life in patients with Barrett's esophagus?
    Gerson LB; Ullah N; Hastie T; Goldstein MK
    Gastrointest Endosc; 2007 Jan; 65(1):16-25. PubMed ID: 17185075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
    Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
    Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-derived health state utilities for gastroesophageal reflux disease.
    Gerson LB; Ullah N; Hastie T; Triadafilopoulos G; Goldstein M
    Am J Gastroenterol; 2005 Mar; 100(3):524-33. PubMed ID: 15743346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade dysplasia in Barrett's esophagus has a high risk of progression.
    Lim CH; Treanor D; Dixon MF; Axon AT
    Endoscopy; 2007 Jul; 39(7):581-7. PubMed ID: 17611911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.
    Barr H; Kendall C; Bazant-Hegemark F; Moayyedi P; Shetty G; Stone N
    MedGenMed; 2006 Jun; 8(2):66. PubMed ID: 16926805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Barrett's esophagus.
    Spechler SJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].
    Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E
    Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports.
    Curvers WL; Peters FP; Elzer B; Schaap AJ; Baak LC; van Oijen A; Mallant-Hent RM; Ten Kate F; Krishnadath KK; Bergman JJ
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):601-7. PubMed ID: 18679060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
    Gilbert S; Jobe BA
    Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus.
    Pech O; May A; Günter E; Gossner L; Ell C
    Am J Gastroenterol; 2006 Oct; 101(10):2223-9. PubMed ID: 17032186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program.
    Shaheen NJ; Green B; Medapalli RK; Mitchell KL; Wei JT; Schmitz SM; West LM; Brown A; Noble M; Sultan S; Provenzale D
    Gastroenterology; 2005 Aug; 129(2):429-36. PubMed ID: 16083700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus.
    Shalauta MD; Saad R
    Am Fam Physician; 2004 May; 69(9):2113-8. PubMed ID: 15152957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.